| Primary |
| Hypertension |
44.4% |
| Prophylaxis Against Transplant Rejection |
11.1% |
| Cardiac Failure |
8.3% |
| Hyperuricaemia |
5.6% |
| Type 2 Diabetes Mellitus |
5.6% |
| Antiviral Prophylaxis |
2.8% |
| Atrial Fibrillation |
2.8% |
| Depression |
2.8% |
| Diabetes Mellitus |
2.8% |
| Erysipelas |
2.8% |
| Gastritis |
2.8% |
| Gout |
2.8% |
| Hypothyroidism |
2.8% |
| Product Used For Unknown Indication |
2.8% |
|
| Agitation |
14.3% |
| Erythema |
14.3% |
| Leukocytoclastic Vasculitis |
14.3% |
| Myopathy |
14.3% |
| Overdose |
14.3% |
| Tremor |
14.3% |
| Vomiting |
14.3% |
|
| Secondary |
| Hypertension |
31.4% |
| Product Used For Unknown Indication |
28.2% |
| Drug Use For Unknown Indication |
8.0% |
| Type 2 Diabetes Mellitus |
5.5% |
| Essential Hypertension |
3.6% |
| Atrial Fibrillation |
3.5% |
| Myocardial Ischaemia |
2.9% |
| Diabetes Mellitus |
2.5% |
| Breast Cancer |
2.3% |
| Thrombosis Prophylaxis |
1.6% |
| Upper Respiratory Tract Infection |
1.5% |
| Blood Pressure |
1.4% |
| Ear Infection |
1.4% |
| Depression |
1.1% |
| Arrhythmia |
1.0% |
| Blood Cholesterol Increased |
0.9% |
| Bronchopneumonia |
0.9% |
| Epilepsy |
0.8% |
| Cardiovascular Event Prophylaxis |
0.7% |
| Gout |
0.7% |
|
| Hyponatraemia |
10.8% |
| Renal Failure Acute |
10.0% |
| Vomiting |
9.2% |
| Oedema Peripheral |
8.3% |
| Hypoglycaemia |
5.0% |
| Loss Of Consciousness |
5.0% |
| Throat Irritation |
5.0% |
| Liver Function Test Abnormal |
4.2% |
| Orthostatic Hypotension |
4.2% |
| Sudden Death |
4.2% |
| Toxic Skin Eruption |
4.2% |
| Cytolytic Hepatitis |
3.3% |
| Dehydration |
3.3% |
| Dyspnoea |
3.3% |
| Hypotension |
3.3% |
| Ischaemic Stroke |
3.3% |
| Leukocytoclastic Vasculitis |
3.3% |
| Myocardial Infarction |
3.3% |
| Nocturia |
3.3% |
| Pancreatitis Acute |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.2% |
| Hypertension |
25.5% |
| Drug Use For Unknown Indication |
11.7% |
| Type 2 Diabetes Mellitus |
3.3% |
| Atrial Fibrillation |
3.2% |
| Diabetes Mellitus |
3.1% |
| Prophylaxis |
2.8% |
| Rheumatoid Arthritis |
2.3% |
| Osteoporosis |
1.9% |
| Hepatitis C |
1.7% |
| Depression |
1.6% |
| Coronary Artery Disease |
1.6% |
| Hypercholesterolaemia |
1.5% |
| Pain |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Multiple Myeloma |
1.3% |
| Renal Transplant |
1.3% |
| Non-small Cell Lung Cancer |
1.2% |
| Thrombosis Prophylaxis |
1.1% |
| Hiv Infection |
1.0% |
|
| Renal Failure Acute |
11.6% |
| Vomiting |
8.9% |
| Weight Decreased |
6.4% |
| Renal Impairment |
6.1% |
| Death |
5.5% |
| Renal Failure |
5.5% |
| Palpitations |
4.9% |
| Pyrexia |
4.6% |
| Diarrhoea |
4.3% |
| Pulmonary Embolism |
4.3% |
| Thrombocytopenia |
4.3% |
| Cerebrovascular Accident |
4.0% |
| Drug Interaction |
4.0% |
| Dyspnoea |
3.7% |
| Hypertension |
3.7% |
| International Normalised Ratio Increased |
3.7% |
| Liver Function Test Abnormal |
3.7% |
| Rash |
3.7% |
| Sepsis |
3.7% |
| White Blood Cell Count Increased |
3.7% |
|
| Interacting |
| Product Used For Unknown Indication |
65.6% |
| Hypertension |
13.2% |
| Lower Respiratory Tract Infection |
5.2% |
| Supraventricular Tachycardia |
5.2% |
| Hiv Infection |
2.8% |
| Diabetes Mellitus |
1.9% |
| Restlessness |
1.4% |
| Back Pain |
0.9% |
| Benign Prostatic Hyperplasia |
0.9% |
| Peripheral Arterial Occlusive Disease |
0.9% |
| Blood Cholesterol Increased |
0.5% |
| Hypothyroidism |
0.5% |
| Ischaemic Heart Disease Prophylaxis |
0.5% |
| Trigeminal Neuralgia |
0.5% |
|
| Hypotension |
28.6% |
| Atrial Fibrillation |
21.4% |
| Drug Interaction |
10.7% |
| Dizziness |
7.1% |
| Hypoglycaemia |
7.1% |
| Tachycardia |
7.1% |
| Ventricular Extrasystoles |
7.1% |
| Product Quality Issue |
3.6% |
| Syncope |
3.6% |
| Trigeminal Neuralgia |
3.6% |
|
